Cherry Cheng, PharmD., RPh., MSc HTA, is a dedicated professional in market access strategy, pricing, and health economics, currently serving as a Market Access Manager in Immunology at Eli Lilly and Company. They have extensive experience in various pharmaceutical roles, including positions at AstraZeneca as a Pricing and Payer Negotiations Manager and at Ipsen as a Specialist in Global Market Access and Pricing. Cherry completed advanced pharmacy practice experiences in hospital settings, enhancing their clinical and counseling skills. They hold a Doctor of Pharmacy degree from the University of Toronto and are pursuing a Master of Health Technology Assessment from the University of Glasgow.
This person is not in the org chart
This person is not in any teams
This person is not in any offices